Investigation of the differences between various renal tumor portions in MRI and tissue examination
Descrizione riassuntiva dello studio
The therapy and prognosis of renal tumors strongly depend on the exact tumor type, which is determined by biopsy, especially in patients whose tumors have already formed metastases and in very old and sick patients. Due to possible differences between various tumor portions, assessment based on a single tissue sample is often difficult. Magnetic resonance imaging (MRI) allows for a very precise representation of the tumor. Thanks to new techniques, statements about the tissue composition in the tumor are also possible, which could provide insights into its aggressiveness and thus the patient's prognosis. This could enable targeted tissue samples from the most aggressive portions and thus a better assessment of the prognosis.
(BASEC)
Intervento studiato
Patients included in the study will undergo an MRI examination, which will include not only standard sequences but also some new study techniques. No additional contrast agent will be administered.
(BASEC)
Malattie studiate
The study aims to improve the diagnostic assessment of renal tumors.
(BASEC)
The following patients may be included in the study: - Patients suspected of having a renal tumor with a minimum size of approximately 2 cm - Patient age ≥ 18 years - Patient's consent to the study (BASEC)
Criteri di esclusione
Patients who meet any of the following statements unfortunately cannot participate in the study: - Pregnant or breastfeeding women - Lack of ability to participate in the study due to language problems, mental illnesses, dementia, etc. - Presence of non-MRI-compatible metallic or electronic implants (pacemakers, shrapnel or other metallic foreign bodies, neurostimulators, etc.). (BASEC)
Luogo dello studio
Zurigo
(BASEC)
Sponsor
University Hospital Zurich
(BASEC)
Contatto per ulteriori informazioni sullo studio
Persona di contatto in Svizzera
PD Dr. A. Hötker
+41 43 254 41 10
radiologie@clutterusz.chUniversity Hospital Zurich
(BASEC)
Informazioni scientifiche
non disponibile
Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)
Commissione etica Zurigo
(BASEC)
Data di approvazione del comitato etico
05.08.2022
(BASEC)
ID di studio ICTRP
non disponibile
Titolo ufficiale (approvato dal comitato etico)
Tumor heterogeneity of renal tumors assessed by multiparametric MRI with direct radiological-histopathological correlation: an explorative study (BASEC)
Titolo accademico
non disponibile
Titolo pubblico
non disponibile
Malattie studiate
non disponibile
Intervento studiato
non disponibile
Tipo di studio
non disponibile
Disegno dello studio
non disponibile
Criteri di inclusione/esclusione
non disponibile
non disponibile
Endpoint primari e secondari
non disponibile
non disponibile
Data di registrazione
non disponibile
Inclusione del primo partecipante
non disponibile
Sponsor secondari
non disponibile
Contatti aggiuntivi
non disponibile
ID secondari
non disponibile
Risultati-Dati individuali dei partecipanti
non disponibile
Ulteriori informazioni sullo studio
non disponibile
Risultati dello studio
Riepilogo dei risultati
non disponibile
Link ai risultati nel registro primario
non disponibile